Outlook Therapeutics, Inc.OTLKNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-67.06T
↓ 900% below average
Average (9y)
$-6.71T
Historical baseline
Range
High:$-26.80M
Low:$-67.06T
CAGR
+380.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-67.06T | -93020833.2% |
| 2024 | $-72.09M | -25.7% |
| 2023 | $-57.38M | +10.8% |
| 2022 | $-64.36M | -24.9% |
| 2021 | $-51.51M | -42.3% |
| 2020 | $-36.20M | -16.4% |
| 2019 | $-31.11M | -16.1% |
| 2018 | $-26.80M | +10.8% |
| 2017 | $-30.03M | +38.7% |
| 2016 | $-48.95M | - |